Search

Displaying results 7861 - 7870 of 10000 in total
  1. Drug

    Premazepam

    go.drugbank.com/drugs/DB21027
    Experimental

    Premazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Premazepam is a diazepam derivative. Premazepam has a monoisotopic molecular weight of 253.12 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  2. Drug

    Elfazepam

    go.drugbank.com/drugs/DB21142
    Experimental

    Elfazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Elfazepam is a diazepam derivative. Elfazepam has a monoisotopic molecular weight of 408.07 Da.

    Categories: Heterocyclic Compounds, 2-Ring
  3. Drug

    Maroxepin

    go.drugbank.com/drugs/DB21379
    Experimental

    Maroxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Maroxepin is a tricyclic compound. Maroxepin has a monoisotopic molecular weight of 277.15 Da.

    Categories: Heterocyclic Compounds, 3-Ring
  4. Drug

    Reclazepam

    go.drugbank.com/drugs/DB21411
    Experimental

    Reclazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Reclazepam is a diazepam derivative. Reclazepam has a monoisotopic molecular weight of 373.04 Da.

  5. Drug

    Metoxepin

    go.drugbank.com/drugs/DB21433
    Experimental

    Metoxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Metoxepin is a tricyclic compound. Metoxepin has a monoisotopic molecular weight of 322.17 Da.

  6. Drug

    Lonodelestat

    go.drugbank.com/drugs/DB21452
    Experimental

    Lonodelestat is a small molecule drug. The usage of the INN stem '-elestat' in the name indicates that Lonodelestat is a elastase inhibitor. … Lonodelestat has a monoisotopic molecular weight of 1477.82 Da.

  7. Drug

    Davelizomib

    go.drugbank.com/drugs/DB21660
    Experimental

    Davelizomib is a small molecule drug. The usage of the INN stem '-zomib' in the name indicates that Davelizomib is a proteasome inhibitor. Davelizomib has a monoisotopic molecular weight of 481.18 Da.

  8. Drug

    Covax-19™

    go.drugbank.com/drugs/DB15846
    Investigational

    Phase 2 and 3 trials are planned for September 2020, and the vaccine is expected to launch early in 2021. … As of June 2020, the vaccine is in Phase 1 trials to evaluate safety and immune responses (NCT04428073).

  9. Drug

    Neladalkib

    go.drugbank.com/drugs/DB21712
    Investigational

    Neladalkib is a small molecule drug. The usage of the INN stem '-alkib' in the name indicates that Neladalkib is a ALK (anaplastic lymphoma kinase) inhibitor. … Neladalkib is under investigation in clinical trial NCT06765109 (Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC).

    Synonyms: an orally bioavailable ALK inhibitor (a macrocyclic compound containing nitrogen heterocycles)
  10. Drug

    Relutrigine

    go.drugbank.com/drugs/DB21614
    Investigational

    Relutrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Relutrigine is a sodium channel blocker, signal transduction modulator. … Relutrigine is under investigation in clinical trial NCT07010471 (A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine).